aTyr Pharma Class Action Lawsuit: Key Takeaways and Statistics

Strategic Insights

Nov 1, 2025 — 1 min read

Purchasers of aTyr Pharma common stock between January 16, 2025 and September 12, 2025, may be entitled to compensation due to allegedly false and misleading statements made by the company about the efficacy of Efzofitimod. A class action lawsuit has been filed, and investors have until December 8, 2025, to move the Court to serve as lead plaintiff. The Rosen Law Firm, a global investor rights law firm, is leading the litigation.

Key Takeaways:

aTyr Pharma allegedly provided false and misleading statements about the efficacy of Efzofitimod, specifically regarding its capability to allow patients to completely taper their steroid usage.
Purchasers of aTyr Pharma common stock between January 16, 2025 and September 12, 2025, may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.
A class action lawsuit has already been filed, and investors have until December 8, 2025, to move the Court to serve as lead plaintiff.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
The firm has secured hundreds of millions of dollars for investors, including over $438 million in 2019 alone.
The firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Laurence Rosen, Esq. and Phillip Kim, Esq. are the lead attorneys on the case.

Statistics:

$438 million: The amount secured by The Rosen Law Firm for investors in 2019.
2019: The year in which The Rosen Law Firm secured over $438 million for investors.
2013: The year in which The Rosen Law Firm was ranked as a top 4 securities firm.
2017: The year in which The Rosen Law Firm was ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements.
2020: The year in which Laurence Rosen was named a Titan of Plaintiffs' Bar by Law360.

Sources:

GlobeNewswire, "aTyr Pharma Class Action Lawsuit: Important December 8, 2025 Lead Plaintiff Deadline" (November 02, 2025)
The Rosen Law Firm, P.A., "aTyr Pharma Class Action Lawsuit" (N/A)

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients